UBXN11 and idiopathic pulmonary fibrosis: Intriguingly, after D + Q treatment of senescent IPF fibroblasts, GDF-15 levels were significantly higher when compared to SOC drugs, suggesting that D + Q might be altering the synthetic activity of senescent IPF, which in turn might further contribute to the fibrotic process mediated by fibroblast progenitor or progeny.